Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants
Amy L. Pasternak, William Tackett, Mousumi Banerjee, Simi Paul, Emily Bertucci-Richter, Xiang Zhou, Vaibhav Sahai, Daniel L. Hertz The Pharmacogenomics Journal
· Springer Nature
· 2026-10-12
· DOI: 10.1038/s41397-026-00432-2
Аннотация
The Pharmacogenomics Journal, Published online: 12 October 2026; doi:10.1038/s41397-026-00432-2 Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants
Amy L. Pasternak, William Tackett, Mousumi Banerjee, Simi Paul, Emily Bertucci-Richter, Xiang Zhou et al. Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants. // The Pharmacogenomics Journal. – 2026. – DOI: 10.1038/s41397-026-00432-2. – URL: https://www.nature.com/articles/s41397-026-00432-2
Amy L. Pasternak, William Tackett, Mousumi Banerjee, Simi Paul, Emily Bertucci-Richter, Xiang Zhou, Vaibhav Sahai, & Daniel L. Hertz (2026). Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants. The Pharmacogenomics Journal. https://doi.org/10.1038/s41397-026-00432-2
Amy L. Pasternak, et al. “Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants.” The Pharmacogenomics Journal, 2026. doi:10.1038/s41397-026-00432-2.
@article{Pasternak2026,
title = {Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants},
author = {Pasternak, Amy L. and Tackett, William and Banerjee, Mousumi and Paul, Simi and Bertucci-Richter, Emily and Zhou, Xiang and Sahai, Vaibhav and Hertz, Daniel L.},
journal = {The Pharmacogenomics Journal},
year = {2026},
doi = {10.1038/s41397-026-00432-2},
url = {https://www.nature.com/articles/s41397-026-00432-2}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’